Deep Learning‐Guided Molecular Docking for Rapid Identification of Novel HER2 Inhibitors in Breast Cancer Therapy

Documenti analoghi

• In Silico Identification and Molecular Dynamics Analysis of PfLysRS Inhibitors for Malaria Treatment
  di: Hayaa M. Alhuthali, et al.
  Pubblicazione: (2026)
• Discovery of Novel Dual EGFR/HER2 Inhibitors Using Integrated Docking, Molecular Dynamics, and MMGBSA Computational Approaches
  di: Karim El Mehdi, et al.
  Pubblicazione: (2025)
• Identification of Potent Inhibitors of Alzheimer's Disease Based on Benzodioxin‐Thiosemicarbazide Analogues and Molecular Docking Study
  di: Muhammad Taha, et al.
  Pubblicazione: (2025)
• Design, Synthesis, Molecular Docking, and in vitro Cytotoxicity Studies of Marine Natural Product Herdmanine Derivatives as Multitarget Inhibitor for EGFR and HER2 Breast Cancer Proteins
  di: Gunjan, et al.
  Pubblicazione: (2024)
• 4‐Thiazolidinone Derivatives as PARP‐1 Inhibitors Targeting Breast Cancer: Integrating DFT, Molecular Docking, Molecular Dynamics Simulations, and ADMETox Analysis
  di: Meenakshi Negi, et al.
  Pubblicazione: (2026)